ARS PharmaceuticalsSPRY
那斯達克 · USD
11.65
+0.01
(+0.09%)
收盤 01/01 04:59 (UTC+8)
01/01 04:59 (UTC+8)
ARS PharmaceuticalsSPRY
11.65
+0.01
(+0.09%)
財務數據
損益表
- 0.00
- -
- -
- -
- 0.01
- 0.02
- 0.87
- 0.08
- 0.16
- 0.33
- -50.00
- -
- -
- -
- -
- 313.60
- 4086.70
- -90.79
- 97.13
- 106.79
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 32,501 | 15,717 | 7,973 | 86,581 | 2,068 | 500 | - | - | - | 10 |
營業成本 | 8,191 | 4,984 | 1,094 | 865 | 112 | - | - | - | - | - |
營業毛利 | 24,310 | 10,733 | 6,879 | 85,716 | 1,956 | 500 | - | - | - | 10 |
營業費用 | 77,502 | 58,347 | 44,056 | 38,519 | 23,704 | 15,840 | - | - | 17,978 | 20,613 |
研發費用 | 2,751 | 4,035 | 2,952 | 3,027 | 4,423 | 6,896 | 5,234 | 3,404 | 3,002 | 7,308 |
推銷及管理費用 | 74,751 | 54,312 | 41,104 | 35,492 | 19,281 | 8,944 | 7,958 | 6,822 | 14,976 | 13,305 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -53,192 | -47,614 | -37,177 | 47,197 | -21,748 | -15,340 | -13,192 | -10,226 | -17,978 | -20,603 |
其他收入及費用 | 2,041 | 2,731 | 3,237 | 3,025 | 2,620 | 2,824 | 2,900 | 3,058 | 3,112 | 3,233 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -51,151 | -44,883 | -33,940 | 50,222 | -19,128 | -12,516 | -10,292 | -7,168 | -14,866 | -17,370 |
所得稅 | - | - | - | 288 | - | - | - | - | - | - |
稅後純益 | -51,151 | -44,883 | -33,940 | 49,934 | -19,128 | -12,516 | -10,292 | -7,168 | -14,866 | -17,370 |
基本每股稅後盈餘(元) | -0.52 | -0.46 | -0.35 | - | -0.20 | -0.13 | -0.11 | - | -0.16 | -0.18 |
稀釋每股稅後盈餘(元) | -0.52 | -0.46 | -0.35 | 0.51 | -0.19 | -0.13 | -0.11 | -0.07 | -0.16 | -0.18 |
基本平均股數(千股) | 98807.00 | 98361.00 | 98060.00 | - | 97032.00 | 96827.00 | 96486.00 | - | 95576.00 | 94911.00 |
稀釋平均股數(千股) | 98807.00 | 98361.00 | 98060.00 | - | 97032.00 | 96827.00 | 96486.00 | - | 95576.00 | 94911.00 |
還原基本每股稅後盈餘(元) | -0.52 | -0.46 | -0.35 | - | -0.20 | -0.13 | -0.11 | - | -0.16 | -0.18 |
還原稀釋每股稅後盈餘(元) | -0.52 | -0.46 | -0.35 | 0.51 | -0.19 | -0.13 | -0.11 | -0.07 | -0.16 | -0.18 |
還原基本平均股數(千股) | 98,807 | 98,361 | 98,060 | - | 97,032 | 96,827 | 96,486 | - | 95,576 | 94,911 |
還原稀釋平均股數(千股) | 98,807 | 98,361 | 98,060 | - | 97,032 | 96,827 | 96,486 | - | 95,576 | 94,911 |
EBITDA(千元) | -51,852 | -46,071 | -35,621 | 48,707 | -20,933 | -14,402 | -12,261 | -8,913 | -16,405 | -19,102 |